Target intelligence / Profile preview

OTU domain-containing protein 3 (OTUD3)

Target
OTUD3
Molecular classification
Enzyme, Cysteine-type deubiquitinase, Hydrolase (structural class), Member of OTU (ovarian tumor) family of deubiquitinases
01

Overview

OTU domain-containing protein 3 (OTUD3) is a cysteine protease and member of the OTU family of deubiquitinases, which selectively cleaves ubiquitin chains from substrate proteins, most notably Lys6- and Lys63-linked chains. OTUD3 is involved in multiple cellular processes including stabilization of tumor suppressors (e.g., PTEN, p53), regulation of metabolic proteins (e.g., IRP2, PPARδ), control of innate immunity (viral response via MAVS, RIG-I, cGAS), and negative regulation of ribosomal protein ubiquitination. Expression and function of OTUD3 are tightly regulated by post-translational modifications and microRNAs. It is abnormally expressed in many cancers and diseases, acting variably as a tumor suppressor or oncogene. OTUD3 has emerged as a promising therapeutic target with experimental small-molecule inhibitors being developed for cancer and other diseases.

Other names
OTUD3OTU deubiquitinase 3OTU domain containing 3KIAA0459DUBA4
02

Mechanism of action

Inhibition of deubiquitinase activity (by small molecule inhibitors like OTUDin3) reduces stabilization of OTUD3 substrates, promoting their degradation and impacting tumorigenesis. Deubiquitination of specific lysine-linked ubiquitin chains (primarily Lys6 and Lys63, but also Lys11, Lys27, and Lys48) on substrate proteins, affecting their stability and downstream signaling.

03

Biological functions

Protein deubiquitination (removal of ubiquitin chains from substrates)Regulation of innate immunity and inflammationMetabolic regulation and cellular response to nutrient levelsProtein stabilization (especially tumor suppressors and metabolic proteins)Regulation of ribosome-associated quality controlDNA damage response (speculative)Negative regulation of phosphatidylinositol 3-kinase/AKT signaling
04

Disease associations

Cancer (breast, lung, hepatocellular carcinoma, colorectal cancer)Neurodegenerative disease (e.g., Parkinson's disease via iron metabolism regulator IRP2)InflammationDiabetesInfection (antiviral and pro-viral immune responses)Other metabolic diseases (e.g., clinical mastitis in cows)
05

Safety considerations

Potential for dual roles as either tumor suppressor or oncogene depending on context (tumor type and substrate profile)Systemic effects on immunity and metabolism (modulation of immune responses, impact on iron homeostasis)Off-target effects of deubiquitinase inhibitors in normal tissue, especially brain and metabolic tissues (due to high OTUD3 expression)
06

Interacting drugs

OTUDin3
07

Biomarkers

OTUD3 expression levels (elevated in several tumors, e.g., colorectal cancer, lung cancer)Substrate stabilization status (PTEN, GRP78, IRP2, YY1—as indicative of OTUD3 activity)

Beyond the preview

Go deeper on OTU domain-containing protein 3 (OTUD3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on OTU domain-containing protein 3 (OTUD3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call